Japan’s Shionogi Grants US Company the Rights to Develop a Repurposed Allergic Rhinitis Drug as a COVID-19 Cure
COVID-19 drugs have become a huge market where every company is eager to enter. However, due to the high R&D cost and the highly competitive market, it’s challenging to squeeze …
Read More